Baird Medical Investment Holdings Limited (BDMD) — Cash Flow Reinvestment Rate
Baird Medical Investment Holdings Limited (BDMD) has a Cash Flow Reinvestment Rate of 1.97x as of June 2023, reinvesting $1.26 Million (capex $1.26 Million ) from operating cash flow of $642.95K. Explore Baird Medical Investment Holdings Limite capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Baird Medical Investment Holdings Limited Cash Flow Reinvestment Rate (2019–2022)
Historical reinvestment intensity for Baird Medical Investment Holdings Limited across 4 annual periods. Also explore BDMD asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Baird Medical Investment Holdings Limited (2019–2022)
Year-by-year capital reinvestment analysis for Baird Medical Investment Holdings Limited. For live market cap and broader valuation context, see BDMD stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 24.44x | $11.88 Million | $485.97K | $5.95 Million | ▲ +4528.2% |
| 2021 | 0.53x | $2.77 Million | $5.26 Million | $1.39 Million | ▲ +214.8% |
| 2020 | 0.17x | $655.35K | $3.91 Million | $655.35K | ▼ -24.8% |
| 2019 | 0.22x | $983.78K | $4.41 Million | $983.78K | — |